Russian Direct Investment Fund

Timelines
India to get limited doses of Sputnik V by April-end

13 Apr 2021

India to get limited doses of Sputnik V by April-end

Sputnik V, the Russia-made coronavirus vaccine, will be manufactured in India by five pharmaceutical firms. It is estimated that 850 million doses will be produced yearly.

Indian drugmaker to produce 200mn doses of Russia's Sputnik V

19 Mar 2021

Indian drugmaker to produce 200mn doses of Russia's Sputnik V

Stelis Biopharma, the biopharmaceutical arm of Bengaluru-based Strides Pharma Science, will be making and supplying at least 200 million doses of the Sputnik V vaccine, the Russian coronavirus vaccine currently awaiting emergency use approval in India.

Russia, AstraZeneca to test combination of COVID-19 shots

22 Dec 2020

Russia, AstraZeneca to test combination of COVID-19 shots

Developers of the Russian coronavirus vaccine Sputnik V on Monday announced signing an agreement with AstraZeneca to test a combination of the British drug maker's COVID-19 shots and a component of the vaccine created in Moscow.

COVID-19 vaccine: India to produce 300 million Sputnik V doses

18 Dec 2020

COVID-19 vaccine: India to produce 300 million Sputnik V doses

India will reportedly produce around 300 million doses of the Russian COVID-19 vaccine called Sputnik V.

Putin orders Russian authorities to start mass COVID-19 vaccinations

02 Dec 2020

Putin orders Russian authorities to start mass COVID-19 vaccinations

Russian President Vladimir Putin on Wednesday ordered authorities to start mass voluntary vaccinations for COVID-19.

India to produce 100 million Sputnik V doses starting 2021

27 Nov 2020

India to produce 100 million Sputnik V doses starting 2021

India will produce over 100 million doses a year of the Russian COVID-19 vaccine Sputnik V starting 2021, under an agreement between the Russian Direct Investment Fund (RDIF) and Hyderabad-based Hetero Biopharma, Hindustan Times reported.

Russia's Sputnik V at least 91% effective, early data suggests

24 Nov 2020

Russia's Sputnik V at least 91% effective, early data suggests

The Russian vaccine for COVID-19, called Sputnik V, has been found at least 91% effective in the second interim analysis.

Russia's Sputnik V to start human trials in India soon

22 Nov 2020

Russia's Sputnik V to start human trials in India soon

Russia's COVID-19 vaccine candidate, called Sputnik V, is expected to start human trials in India soon.

Sputnik V Phase-II trials to have 100 volunteers: Dr. Reddy's

25 Oct 2020

Sputnik V Phase-II trials to have 100 volunteers: Dr. Reddy's

Phase II clinical trials for the Russian COVID-19 vaccine, Sputnik V, will have 100 volunteers, the Indian Central Drugs Standard Control Organisation's Drug Controller General (DCGI) has told Sputnik.

India rejects large scale trial of Russia's COVID-19 vaccine

08 Oct 2020

India rejects large scale trial of Russia's COVID-19 vaccine

India's drug regulator has refused to allow a large scale clinical trial of Russia's Sputnik V COVID-19 vaccine.

One in seven volunteers for Sputnik V report side effects

18 Sep 2020

One in seven volunteers for Sputnik V report side effects

Sputnik V, the COVID-19 vaccine developed and approved by Russia, has shown side effects in some trial volunteers.

Dr. Reddy's bringing coronavirus vaccine to India by 2020-end

16 Sep 2020

Dr. Reddy's bringing coronavirus vaccine to India by 2020-end

In a major development, Hyderabad-based pharma company Dr. Reddy's Laboratories has partnered with the Russian Direct Investment Fund (RDIF) to source their Sputnik V COVID-19 vaccine for India.

Russia looking to partner with India for COVID-19 vaccine production

21 Aug 2020

Russia looking to partner with India for COVID-19 vaccine production

Russia has been in the headlines for its two-month-tested 'Sputnik V' COVID-19 vaccine.

Russia's COVID-19 vaccine candidate to be registered this week

09 Aug 2020

Russia's COVID-19 vaccine candidate to be registered this week

Russian health officials are set to register a vaccine candidate for the novel coronavirus disease, COVID-19, as early as this week.